Without measuring diagnostic errors, it will be impossible to hold people accountable and reduce them.
The September report from the Institute of Medicine highlighted how common and costly diagnostic errors can be. It defined such an error as failing to establish an accurate and timely explanation of a patient’s health problem or failing to communicate that explanation to the patient.
Taking on this problem, according to 3 authors writing in JAMA, requires measuring the scope of diagnostic errors, because reducing them starts with figuring out how back the problem is. The authors are no strangers to measurement: Elizabeth A. McGlynn, PhD, Kaiser Permanente Center for Effectiveness and Safety Research and the Center for Primary Care and Outcomes Research; Kathryn M. McDonald, MM, of the Center for Health Policy, Stanford University; and Christine K. Cassel, MD, president and CEO, the National Quality Forum.
The authors outline 5 purposes for measuring diagnostic errors: to establish the magnitude of the problem, to determine the causes and risks of diagnostic error, to evaluate the effectiveness of interventions, to assess skills in education and training, and to establish accountability in diagnostic performance. Assuming that the current steps toward promoting value-based care, such as pay-for-performance incentives, would be naïve. Training must emphasize clinical reasoning skills as well as the appropriate use of tests and technology.
Just as the current healthcare reform efforts are demanding more patient engagement, so, too, much other stakeholders be engaged in the movement for better diagnostic processes. Feedback is critical, and so is research. The federal government must take a lead role—and it must be the mission of an agency, as at the moment is it not. This will not be acceptable, the authors suggest, because of “the demand for public reporting of performance measures and increasing use of value-based purchasing in both the public and private sectors.”
The report on diagnostic errors found that despite overall efforts to improve healthcare quality, the essential step in the chain—assessing and diagnosing what is wrong with the patient—has received less than adequate attention. The 21-member Committee on Diagnostic Error in Health Care examined the diagnostic process in light of the following:
Reference
McGlynn EA, McDonald KM, Cassel CK. Measurement is essential for improving diagnosis and reducing diagnostic error. JAMA. 2015;314(23):2501-2502.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
2 Commerce Drive
Cranbury, NJ 08512